Health Condition 1: null- ASA 1/2 pateints with concomitant CBD stones and gall stones
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with both symptomatic gall stones and choledocholithiasis 2.Patients in whom a prior ERCP had failed to extract a CBD stone Failure of ERCP will be defined as: 1.Unsuitable anatomy such as gastric outlet obstruction, large periampullary diverticulum 2.Failure to cannulate the bile duct 3.Failure to perform adequate sphincterotomy 4.Failure to extract the stone for various reasons such as large stone, impacted stones and/or multiple stones
Exclusion criteria
Exclusion criteria: 1.Patients with acute cholecystitis 2.Patients with acute cholangitis 3.Patients with obstructive jaundice with serum bilirubin > 15mg/dl 4.Patients with post ERCP pancreatitis 5.Patients who do not give consent for participate in the study 6.Patients with previous hepatobiliary surgery 7.Patients with morbid obesity 8.Patients with uncorrectable coagulopathy 9.Patients unfit for GA 10.Patients with significant comorbid conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ To assess the success and complications of laparoscopic CBD exploration for choledocholithiasis after unsuccessful endoscopic stone extraction to extract common bile duct stones â?¢ To compare the success, ease of surgery and complications between primary laparoscopic CBD exploration and laparoscopic CBD exploration following unsuccessful endoscopic stone extraction Timepoint: All patients will be followed postoperatively at 1 week, 3 months, 6 months and at one year or till the time they are stone free. Postoperative course of the patients will be noted | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications, hospital stay, and cost effectivenessTimepoint: Post operative | — |
Countries
India
Contacts
All India Institute of Medical Sciences, New Delhi, India